A novel use of the known protein Erythropoietin (EPO) and/or a derivative and/or a fragment thereof is disclosed. EPO is used as a pharmaceutical for the treatment of chronic inflammations. A particularly beneficial result is seen in patients suffering from rheumatoid arthritis (RA). Significant effects are seen in clinical variables such as morning stiffness, swollen joints, and the like.

 
Web www.patentalert.com

< Stabilized lanthanum carbonate compositions

> Self-replicating RNA molecule from hepatitis C virus

~ 00418